Skip to main content

Advertisement

Log in

Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Alpha-fetoprotein (AFP)-producing adenocarcinoma is known for its rapid progression and poor prognosis, and chemotherapy regimens are yet to be standardized. Here we describe the first report of AFP-producing adenocarcinoma with calcification. The metastatic route was visualized from the calcification, and combination chemotherapy was performed. A 77-year-old Japanese man was transferred to our hospital for treatment of liver tumors. Computed tomography (CT) revealed multiple liver tumors with portal vein tumor thrombosis. The tumors were highly attenuated before enhancement, suggesting various degrees of calcification. Serum levels of carcinoembryonic antigen (CEA), AFP, and the proportion of fucosylated AFP were considerably elevated. Gastroduodenoscopy revealed an elevated tumor occupying the duodenal bulb with an ulcerative lesion in the vicinity of the gastroduodenal junction, and biopsy specimens from the duodenum and liver revealed medullary adenocarcinoma with calcification. Three-dimensional reconstruction of CT images clearly showed that the calcified lesions had spread from the gastroduodenal junction to the liver via a route comprising the corresponding local vein, the superior mesenteric vein, and portal vein. The patient was accordingly diagnosed with calcified AFP-producing adenocarcinoma with multiple liver metastases. Combination chemotherapy using TS-1 and cisplatin (CDDP) resulted in a striking response for the initial 4 months in terms of tumor markers and CT findings. This is the first report of AFP-producing adenocarcinoma with calcification. A metastatic route from the primary tumor to the liver was clearly visualized by tracing the calcified lesions. Combination chemotherapy based on 5-fluorouracil and CDDP may have the potential to prolong survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Gitlin D, Perricelli A, Gitlin GM. Synthesis of alpha-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res. 1972;32:979–82.

    PubMed  CAS  Google Scholar 

  2. Purves LR, Bersohn I, Geddes EW. Serum alpha-feto-protein and primary cancer of the liver in man. Cancer. 1970;25:1261–70.

    Article  PubMed  CAS  Google Scholar 

  3. Umeda K, Heike T, Yoshimoto M, Shiota M, Suemori H, Luo HY, et al. Development of primitive and definitive hematopoiesis from nonhuman primate embryonic stem cells in vitro. Development. 2004;131:1869–79.

    Article  PubMed  CAS  Google Scholar 

  4. Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A. Existence of alpha feto protein during gastric-origin secondary cancer of the liver. Presse Med. 1970;78:1277–8.

    PubMed  CAS  Google Scholar 

  5. Takashima H, Kimura H, Nakamura H, Myojo S, Okuyama Y, Sugeta N, et al. A case of AFP producing endocrine cell carcinoma of the duodenum. Nippon Shokakibyo Gakkai Zasshi. 2002;99:798–802.

    PubMed  Google Scholar 

  6. Gardiner GW, Lajoie G, Keith R. Hepatoid adenocarcinoma of the papilla of Vater. Histopathology. 1992;20:541–4.

    Article  PubMed  CAS  Google Scholar 

  7. Iwai K, Ishikura H, Inoue T, Yoshiki T. A case of AFP-positive pancreas papillary carcinoma suggestive of a primitive endoderm phenotype. Acta Pathol Jpn. 1993;43:434–9.

    PubMed  CAS  Google Scholar 

  8. Tanno S, Obara T, Fujii T, Izawa T, Mizukami Y, Saitoh Y, et al. alpha-Fetoprotein-producing adenocarcinoma of the pancreas presenting focal hepatoid differentiation. Int J Pancreatol. 1999;26:43–7.

    Article  PubMed  CAS  Google Scholar 

  9. Alpert E, Pinn VW, Isselbacher KJ. Alpha-fetoprotein in a patient with gastric carcinoma metastatic to the liver. N Engl J Med. 1971;285:1058–9.

    Article  PubMed  CAS  Google Scholar 

  10. Inagawa S, Shimazaki J, Hori M, Yoshimi F, Adachi S, Kawamoto T, et al. Hepatoid adenocarcinoma of the stomach. Gastric Cancer. 2001;4:43–52.

    Article  PubMed  CAS  Google Scholar 

  11. Chang YC, Nagasue N, Kohno H, Taniura H, Uchida M, Yamanoi A, et al. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am J Gastroenterol. 1990;85:1480–5.

    PubMed  CAS  Google Scholar 

  12. Koide N, Nishio A, Igarashi J, Kajikawa S, Adachi W, Amano J. Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis. Am J Gastroenterol. 1999;94:1658–63.

    PubMed  CAS  Google Scholar 

  13. Ihling C, Schaefer HE, Baumgartner U, Riede UN. Hepatoid adenocarcinoma of the stomach: a case report. Gen Diagn Pathol. 1995;141:61–5.

    PubMed  CAS  Google Scholar 

  14. Kochi M, Fujii M, Kaiga T, Takahashi T, Morishita Y, Kobayashi M, et al. FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Oncology. 2004;66:445–9.

    Article  PubMed  CAS  Google Scholar 

  15. Nakajima T, Ota K, Ishihara S, Oyama S, Nishi M, Ohashi Y, et al. Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann Surg Oncol. 1997;4:203–8.

    Article  PubMed  CAS  Google Scholar 

  16. Shimada S, Hayashi N, Marutsuka T, Baba Y, Yokoyama S, Iyama K, et al. Irinotecan plus low-dose cisplatin for alpha-fetoprotein-producing gastric carcinoma with multiple liver metastases: report of two cases. Surg Today. 2002;32:1075–80.

    Article  PubMed  Google Scholar 

  17. Shiochi H, Yamada M, Kishina M, Murawaki Y, Miura M, Azumi T, et al. A case of AFP-producing gastric cancer responding to the combination of systemic chemotherapy, transcatheter arterial embolization and hepatic infusion chemotherapy. Gan To Kagaku Ryoho. 2009;36:843–6.

    PubMed  Google Scholar 

  18. Takeyama H, Sawai H, Wakasugi T, Takahashi H, Matsuo Y, Ochi N, et al. Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases. World J Surg Oncol. 2007;5:79.

    Article  PubMed  Google Scholar 

  19. Usuba T, Toyama Y, Watanabe K, Kashiwagi H, Yanaga K. Combination chemotherapy using TS-1, paclitaxel and cisplatin for multiple lung metastases from AFP-producing gastric cancer: a case report. Hepatogastroenterology. 2007;54:1302–4.

    PubMed  CAS  Google Scholar 

  20. Motoyama T, Aizawa K, Watanabe H, Fukase M, Saito K. Alpha-fetoprotein producing gastric carcinomas: a comparative study of three different subtypes. Acta Pathol Jpn. 1993;43:654–61.

    PubMed  CAS  Google Scholar 

  21. Ichiishi E, Kogawa T, Takeda S, Yanagida K, Yoshikawa T, Kondo M. Eight cases of gastric tumors with calcification. Intern Med. 1995;34:1038–42.

    Article  PubMed  CAS  Google Scholar 

  22. Michelassi F, Takanishi DM Jr, Pantalone D, Hart J, Chappell R, Block GE. Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. Surgery. 1994;116:804–9. discussion 809–10.

    PubMed  CAS  Google Scholar 

  23. Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5.

    Article  PubMed  Google Scholar 

  24. Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, et al. The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer. 1991;67:2390–4.

    Article  PubMed  CAS  Google Scholar 

  25. Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, et al. High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein. Oncology. 2000;59:145–51.

    Article  PubMed  CAS  Google Scholar 

  26. Kamei S, Kono K, Amemiya H, Takahashi A, Sugai H, Ichihara F, et al. Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein. J Gastroenterol. 2003;38:540–7.

    PubMed  CAS  Google Scholar 

  27. Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg. 2002;19:359–65. discussion 365.

    Article  PubMed  CAS  Google Scholar 

  28. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215–21.

    Article  PubMed  CAS  Google Scholar 

  29. Sohda T, Hanano T, Miyamoto H, Kitano Y, Iwata K, Yokoyama M, et al. Spontaneous rupture of metastatic alpha-fetoprotein-producing gastric cancer of the liver. Hepatol Int. 2008;2:258–61.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Atsunori Tsuchiya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsuchiya, A., Kanefuji, T., Suda, T. et al. Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions. Clin J Gastroenterol 4, 89–94 (2011). https://doi.org/10.1007/s12328-011-0209-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-011-0209-x

Keywords

Navigation